Skip to content

Genetics of Rolandic Epilepsy

Genetics of Rolandic Epilepsy

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00282854
Enrollment
1000
Registered
2006-01-27
Start date
2005-01-31
Completion date
2013-12-31
Last updated
2023-06-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy

Keywords

epilepsy, Rolandic epilepsy

Brief summary

The purpose of this study is to find the genes that cause Rolandic epilepsy and its related traits.

Detailed description

Rolandic epilepsy (RE) is the most common type of childhood epilepsy-affecting more than 50,000 children in the United States-and has a complex genetic inheritance. The seizure prognosis is relatively benign, however, many children with RE also have problems with speech and language, reading, and motor coordination. Symptoms of the disorder overlap with more severe types of epilepsy. The purpose of this study is to find the genes that influence RE and its related traits. Identifying genetic causes for the variants would improve diagnosis and allow for early intervention. Researchers will enroll 1000 children with RE and 3000 controls for participation in the study. The scientists will request medical histories and (salivary) DNA samples from the participants. Participation can be completed by mail and telephone. Results from this study should provide important information regarding diagnosis and prognosis of RE, may be useful in clinical management, and, eventually, may lead to a cure for this and other forms of epilepsy.

Interventions

None listed

Sponsors

National Institute of Neurological Disorders and Stroke (NINDS)
CollaboratorNIH
King's College London
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
3 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Inclusion: * typical history of focal seizures * EEG centrotemporal sharp waves * age of onset 3-12 years * no previous epilepsy type (febrile seizures OK) * normal development * normal neurological examination * normal MRI/CT (if done) Exclusion: * only history of secondary generalized seizures * atypical history/semiology * history and EEG inconsistent * abnormal EEG background * very early (\<3yrs) or late (\>12yrs) onset * global neurodevelopmental deficit * deviant neurodevelopment * structural imaging abnormality

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026